( Furthermore ( , ( ( ( blocking ( ( the activity ) ( of myostatin ) ) ) ( may ( ( have ( therapeutic application ) ) ( in ( treating ( ( muscle ( wasting diseases ) ) ( such ( as ( muscular dystrophy ) ) ) ) ) ) ) ) ) . ) ) )
(ROOT (S (ADVP (RB Furthermore)) (, ,) (VP (VBG blocking) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN myostatin))))) (VP (MD may) (VP (VB have) (NP (JJ therapeutic) (NN application)) (PP (IN in) (S (VP (VBG treating) (NP (NP (NN muscle) (NN wasting) (NNS diseases)) (PP (JJ such) (IN as) (NP (JJ muscular) (NN dystrophy))))))))) (. .)))
Furthermore, blocking the activity of myostatin may have therapeutic application in treating muscle wasting diseases such as muscular dystrophy.
(ROOT (S (NP (JJ Muscular) (NN dystrophy)) (VP (VBZ is) (NP (DT a) (DT a) (NN wasting) (NN disease))) (. .)))